Apoptosis mapping in space and time of 3D tumor ecosystems reveals transmissibility of cytotoxic cancer death.
Journal
PLoS computational biology
ISSN: 1553-7358
Titre abrégé: PLoS Comput Biol
Pays: United States
ID NLM: 101238922
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
23
09
2020
accepted:
12
03
2021
revised:
09
04
2021
pubmed:
31
3
2021
medline:
30
7
2021
entrez:
30
3
2021
Statut:
epublish
Résumé
The emerging tumor-on-chip (ToC) approaches allow to address biomedical questions out of reach with classical cell culture techniques: in biomimetic 3D hydrogels they partially reconstitute ex vivo the complexity of the tumor microenvironment and the cellular dynamics involving multiple cell types (cancer cells, immune cells, fibroblasts, etc.). However, a clear bottleneck is the extraction and interpretation of the rich biological information contained, sometime hidden, in the cell co-culture videos. In this work, we develop and apply novel video analysis algorithms to automatically measure the cytotoxic effects on human cancer cells (lung and breast) induced either by doxorubicin chemotherapy drug or by autologous tumor-infiltrating cytotoxic T lymphocytes (CTL). A live fluorescent dye (red) is used to selectively pre-stain the cancer cells before co-cultures and a live fluorescent reporter for caspase activity (green) is used to monitor apoptotic cell death. The here described open-source computational method, named STAMP (spatiotemporal apoptosis mapper), extracts the temporal kinetics and the spatial maps of cancer death, by localizing and tracking cancer cells in the red channel, and by counting the red to green transition signals, over 2-3 days. The robustness and versatility of the method is demonstrated by its application to different cell models and co-culture combinations. Noteworthy, this approach reveals the strong contribution of primary cancer-associated fibroblasts (CAFs) to breast cancer chemo-resistance, proving to be a powerful strategy to investigate intercellular cross-talks and drug resistance mechanisms. Moreover, we defined a new parameter, the 'potential of death induction', which is computed in time and in space to quantify the impact of dying cells on neighbor cells. We found that, contrary to natural death, cancer death induced by chemotherapy or by CTL is transmissible, in that it promotes the death of nearby cancer cells, suggesting the release of diffusible factors which amplify the initial cytotoxic stimulus.
Identifiants
pubmed: 33784299
doi: 10.1371/journal.pcbi.1008870
pii: PCOMPBIOL-D-20-01728
pmc: PMC8034728
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1008870Déclaration de conflit d'intérêts
IV and HS are Roche employees. IV, AM, MCP, EM filed a patent on the STAMP method.
Références
Mol Cell. 2017 Feb 16;65(4):730-742.e5
pubmed: 28212753
Cell. 2018 Feb 8;172(4):841-856.e16
pubmed: 29395328
J Immunol Methods. 1974 Mar;4(2):301-15
pubmed: 4546189
J Thorac Dis. 2017 Oct;9(10):4017-4026
pubmed: 29268412
Sci Rep. 2020 May 6;10(1):7653
pubmed: 32376840
EMBO Mol Med. 2015 Apr 01;7(6):735-53
pubmed: 25834145
IEEE Trans Biomed Eng. 2019 Oct;66(10):2882-2888
pubmed: 30735982
Nat Protoc. 2013 Nov;8(11):2135-57
pubmed: 24113786
Nat Commun. 2020 Jan 21;11(1):404
pubmed: 31964880
Curr Opin Biotechnol. 2018 Aug;52:116-123
pubmed: 29656237
Dev Cell. 2016 Jul 25;38(2):147-60
pubmed: 27459067
Nature. 2020 Apr;580(7801):130-135
pubmed: 32238926
Int J Radiat Biol. 2018 Aug;94(8):696-707
pubmed: 29095061
J Immunol. 2002 Jul 15;169(2):809-17
pubmed: 12097384
Adv Drug Deliv Rev. 2014 Dec 15;79-80:68-78
pubmed: 25017040
Nat Rev Cancer. 2019 Feb;19(2):65-81
pubmed: 30647431
Mediators Inflamm. 2014;2014:821043
pubmed: 25140116
Front Immunol. 2019 May 28;10:1133
pubmed: 31191524
Cell Death Differ. 2016 Jul;23(7):1110-8
pubmed: 27177021
PLoS One. 2015 Jun 26;10(6):e0129593
pubmed: 26115510
Curr Opin Biotechnol. 2015 Dec;35:118-26
pubmed: 26094109
Cancer Cell. 2018 Mar 12;33(3):463-479.e10
pubmed: 29455927
Curr Protoc Immunol. 2017 Aug 1;118:7.42.1-7.42.12
pubmed: 28762488
Sci Rep. 2019 May 1;9(1):6789
pubmed: 31043687
Cell Syst. 2017 Jun 28;4(6):600-610.e6
pubmed: 28601558
Cancer J. 2003 Jan-Feb;9(1):33-41
pubmed: 12602766
Sci Rep. 2017 Apr 24;7(1):1093
pubmed: 28439087
J Immunol Methods. 1993 Mar 15;160(1):81-8
pubmed: 7680699
J Clin Invest. 2018 Feb 1;128(2):589-606
pubmed: 29251630
Trends Cancer. 2016 Jan 1;2(1):6-19
pubmed: 26858990
Cancer Res. 2020 Jun 1;80(11):2257-2272
pubmed: 32193288
J Biochem Biophys Methods. 1994 Jan;28(1):53-68
pubmed: 8151070
Cell Rep. 2018 Dec 26;25(13):3884-3893.e3
pubmed: 30590056
Cancer Res. 2018 Apr 1;78(7):1700-1712
pubmed: 29363544
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479
Int J Oncol. 2016 Aug;49(2):753-62
pubmed: 27278553